Literature DB >> 19864482

Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006.

Du-Ping Zheng1, Marc-Alain Widdowson, Roger I Glass, Jan Vinjé.   

Abstract

Human noroviruses (NoVs) of genogroup II, genotype 4 (GII.4) are the most common strains detected in outbreaks of acute gastroenteritis worldwide. To gain insight into the epidemiology and genetic variation of GII.4 strains, we analyzed 773 NoV outbreaks reported to the CDC from 1994 to 2006. Of these NoV outbreaks, 629 (81.4%) were caused by GII viruses and 342 (44.2%) were caused by GII.4 strains. The proportion of GII.4 outbreaks increased from 5% in 1994 to 85% in 2006, but distinct annual differences were noted, including sharp increases in 1996, 2003, and 2006 each associated with newly emerging GII.4 strains. Sequence analysis of the full-length VP1 gene of GII.4 strains identified in this study and from GenBank segregated these viruses into at least 9 distinct subclusters which had 1.3 to 3.2% amino acid variation between strains in different subclusters. We propose that GII.4 subclusters be defined as having >5% sequence variation between strains. Our data confirm other studies on the rapid emergence and displacement of highly virulent GII.4 strains.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19864482      PMCID: PMC2812295          DOI: 10.1128/JCM.01622-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  48 in total

1.  Laboratory efforts to cultivate noroviruses.

Authors:  Erwin Duizer; Kellogg J Schwab; Frederick H Neill; Robert L Atmar; Marion P G Koopmans; Mary K Estes
Journal:  J Gen Virol       Date:  2004-01       Impact factor: 3.891

2.  Development and application of a capsid VP1 (region D) based reverse transcription PCR assay for genotyping of genogroup I and II noroviruses.

Authors:  Jan Vinjé; Raditijo A Hamidjaja; Mark D Sobsey
Journal:  J Virol Methods       Date:  2004-03-15       Impact factor: 2.014

3.  Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus--United States, 2002.

Authors:  Marc-Alain Widdowson; Elaine H Cramer; Leslie Hadley; Joseph S Bresee; R Suzanne Beard; Sandra N Bulens; Myrna Charles; Wairimu Chege; Elmira Isakbaeva; Jennifer G Wright; Eric Mintz; David Forney; Jeffrey Massey; Roger I Glass; Stephan S Monroe
Journal:  J Infect Dis       Date:  2004-06-08       Impact factor: 5.226

4.  A predominant role for Norwalk-like viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly.

Authors:  Kim Y Green; Gaël Belliot; Jean Lin Taylor; José Valdesuso; Judy F Lew; Albert Z Kapikian; Feng-Ying C Lin
Journal:  J Infect Dis       Date:  2002-01-03       Impact factor: 5.226

5.  Herd immunity to GII.4 noroviruses is supported by outbreak patient sera.

Authors:  Jennifer L Cannon; Lisa C Lindesmith; Eric F Donaldson; Lauryn Saxe; Ralph S Baric; Jan Vinjé
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

6.  Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant.

Authors:  Ben Lopman; Harry Vennema; Evelyne Kohli; Pierre Pothier; Alicia Sanchez; Anabel Negredo; Javier Buesa; Eckart Schreier; Mark Reacher; David Brown; Jim Gray; Miren Iturriza; Chris Gallimore; Blenda Bottiger; Kjell-Olof Hedlund; Maria Torvén; Carl-Henrik von Bonsdorff; Leena Maunula; Mateja Poljsak-Prijatelj; Janet Zimsek; Gábor Reuter; György Szücs; Béla Melegh; Lennart Svennson; Yvonne van Duijnhoven; Marion Koopmans
Journal:  Lancet       Date:  2004-02-28       Impact factor: 79.321

7.  National epidemic of Lordsdale Norovirus in the UK.

Authors:  I B Vipond; E O Caul; D Hirst; B Carmen; A Curry; B A Lopman; P Pead; M A Pickett; P R Lambden; I N Clarke
Journal:  J Clin Virol       Date:  2004-07       Impact factor: 3.168

8.  Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket.

Authors:  Ming Tan; Pengwei Huang; Jaroslaw Meller; Weiming Zhong; Tibor Farkas; Xi Jiang
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

9.  Viral gastroenteritis outbreaks in Europe, 1995-2000.

Authors:  Ben A Lopman; Mark H Reacher; Yvonne Van Duijnhoven; François-Xavier Hanon; David Brown; Marion Koopmans
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

10.  Early identification of common-source foodborne virus outbreaks in Europe.

Authors:  Marion Koopmans; Harry Vennema; Herre Heersma; Elisabeth van Strien; Yvonne van Duynhoven; David Brown; Marc Reacher; Ben Lopman
Journal:  Emerg Infect Dis       Date:  2003-09       Impact factor: 6.883

View more
  75 in total

1.  Covariation of major and minor viral capsid proteins in norovirus genogroup II genotype 4 strains.

Authors:  Martin Chi-Wai Chan; Nelson Lee; Wing-Shan Ho; Carmen Oi-Kwan Law; Terrence Chi-Kong Lau; Stephen Kwok-Wing Tsui; Joseph Jao-Yiu Sung
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.

Authors:  Gabriel I Parra; Eugenio J Abente; Carlos Sandoval-Jaime; Stanislav V Sosnovtsev; Karin Bok; Kim Y Green
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

Review 3.  Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review.

Authors:  Rishi Desai; Christal D Hembree; Andreas Handel; Jonathan E Matthews; Benjamin W Dickey; Sharla McDonald; Aron J Hall; Umesh D Parashar; Juan S Leon; Benjamin Lopman
Journal:  Clin Infect Dis       Date:  2012-04-04       Impact factor: 9.079

4.  Complete genomic sequence analysis of norovirus isolated from South Korea.

Authors:  Gyu-Cheol Lee; Gyoo Seung Jung; Chan Hee Lee
Journal:  Virus Genes       Date:  2012-07-03       Impact factor: 2.332

5.  Diagnostic accuracy and analytical sensitivity of IDEIA Norovirus assay for routine screening of human norovirus.

Authors:  Verónica Costantini; LaDonna Grenz; Angela Fritzinger; David Lewis; Christianne Biggs; Antony Hale; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

6.  Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition.

Authors:  Maria Malm; Kirsi Tamminen; Suvi Lappalainen; Hanni Uusi-Kerttula; Timo Vesikari; Vesna Blazevic
Journal:  Clin Vaccine Immunol       Date:  2015-04-22

Review 7.  Norovirus Illnesses in Children and Adolescents.

Authors:  Minesh P Shah; Aron J Hall
Journal:  Infect Dis Clin North Am       Date:  2018-03       Impact factor: 5.982

8.  Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013.

Authors:  Everardo Vega; Leslie Barclay; Nicole Gregoricus; S Hannah Shirley; David Lee; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

Review 9.  Norovirus outbreaks: a systematic review of commonly implicated transmission routes and vehicles.

Authors:  E J Bitler; J E Matthews; B W Dickey; J N S Eisenberg; J S Leon
Journal:  Epidemiol Infect       Date:  2013-02-22       Impact factor: 2.451

10.  Proposal for a unified norovirus nomenclature and genotyping.

Authors:  Annelies Kroneman; Everardo Vega; Harry Vennema; Jan Vinjé; Peter A White; Grant Hansman; Kim Green; Vito Martella; Kazuhiko Katayama; Marion Koopmans
Journal:  Arch Virol       Date:  2013-04-25       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.